SWAV - Shockwave Medical Inc Stock Price, Fair Value and News

$334.75

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

SWAV Price Action

Last 7 days

0.2%

Last 30 days

1.5%

Last 90 days

27.1%

Trailing 12 Months

18.9%

SWAV RSI Chart

SWAV Valuation

Market Cap

12.6B

Price/Earnings (Trailing)

76.87

Price/Sales (Trailing)

15.95

EV/EBITDA

63.66

Price/Free Cashflow

75.65

SWAV Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

SWAV Fundamentals

SWAV Revenue

Revenue (TTM)

788.0M

Rev. Growth (Yr)

35.85%

Rev. Growth (Qtr)

7.8%

SWAV Earnings

Earnings (TTM)

163.5M

Earnings Growth (Yr)

41.46%

Earnings Growth (Qtr)

24.92%

SWAV Profitability

EBT Margin

23.29%

Return on Equity

21.75%

Return on Assets

9.95%

Free Cashflow Yield

1.32%

SWAV Investor Care

Shares Dilution (1Y)

2.50%

Diluted EPS (TTM)

4.26

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	788.0M	0	0	0
2023	557.2M	616.6M	671.3M	730.2M
2022	298.9M	363.7M	429.9M	489.7M
2021	84.5M	130.1M	175.7M	237.1M
2020	50.9M	51.1M	59.4M	67.8M
2019	18.2M	25.9M	33.7M	42.9M
2018	4.4M	7.0M	9.6M	12.3M
2017	0	0	0	1.7M

Get all data in R, Python etc through our Historical Stock Data APIs

About Shockwave Medical Inc

ShockWave Medical, Inc., a medical device company, develops intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters for use in our IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter for use in IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.

CEO	Mr. Douglas E. Godshall M.B.A.
WEBSITE	https://shockwavemedical.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	1001

Shockwave Medical Inc Frequently Asked Questions

What is the ticker symbol for Shockwave Medical Inc? What does SWAV stand for in stocks?

SWAV is the stock ticker symbol of Shockwave Medical Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Shockwave Medical Inc (SWAV)?

As of Fri May 31 2024, market cap of Shockwave Medical Inc is 12.57 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of SWAV stock?

You can check SWAV's fair value in chart for subscribers.

Is Shockwave Medical Inc a good stock to buy?

The fair value guage provides a quick view whether SWAV is over valued or under valued. Whether Shockwave Medical Inc is cheap or expensive depends on the assumptions which impact Shockwave Medical Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SWAV.

What is Shockwave Medical Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 31 2024, SWAV's PE ratio (Price to Earnings) is 76.87 and Price to Sales (PS) ratio is 15.95. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SWAV PE ratio will change depending on the future growth rate expectations of investors.